Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Bonetti

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Tumori|May 9, 2015
Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open questionJacopo Giuliani, Salvatore Martelli, Andrea Remo, et al.
Animals : an Open Access Journal From MDPI|March 6, 2021
Towards Zero Zinc Oxide: Feeding Strategies to Manage Post-Weaning Diarrhea in PigletsAndrea Bonetti, Benedetta Tugnoli, Andrea Piva, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
Thymol as an Adjuvant to Restore Antibiotic Efficacy and Reduce Antimicrobial Resistance and Virulence Gene Expression in Enterotoxigenic <i>Escherichia coli</i> StrainsAndrea Bonetti, Benedetta Tugnoli, Andrea Piva, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2020
Financial toxicity and cancer treatments: Help from biosimilars - The explanatory case of bevacizumabJacopo Giuliani, Francesco Fiorica, Vito Albanese, et al.
Recenti Progressi in Medicina|December 20, 2021
The optimal duration of immune checkpoint inhibitors in non-oncogene addicted non-small cell lung cancer: less is more? An open questionJacopo Giuliani, Ugo Navarro, Beatrice Mantoan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 5, 2021
Cost-effectiveness of consolidation durvalumab after chemo-radiotherapy in stage III non-small-cell lung cancer: A cost-effective changeJacopo Giuliani, Maurizio Valentino Infante, Claudio Micheletto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 18, 2011
Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experiencePaolo Piacentini, Emilia Durante, Annarita Trolese, et al.
Recenti Progressi in Medicina|June 15, 2021
Computerization during the antineoplastic compounding process guarantees greater adherence to evidence-based medicine for the prophylaxis of chemotherapy-induced nausea and vomitingJacopo Giuliani, Beatrice Mantoan, Eva Pigozzi, et al.
Journal of Palliative Medicine|June 11, 2013
The effect of palliative care on the assistance of terminally ill cancer patientsJacopo Giuliani, Luisa Andreetta, Oliviero Zanardi, et al.
Frontiers in Veterinary Science|October 16, 2023
A blend of selected botanicals maintains intestinal epithelial integrity and reduces susceptibility to <i>Escherichia coli</i> F4 infection by modulating acute and chronic inflammation <i>in vitro</i>Andrea Bonetti, Andrea Toschi, Benedetta Tugnoli, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Tumori|May 9, 2015
Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open questionJacopo Giuliani, Salvatore Martelli, Andrea Remo, et al.
Animals : an Open Access Journal From MDPI|March 6, 2021
Towards Zero Zinc Oxide: Feeding Strategies to Manage Post-Weaning Diarrhea in PigletsAndrea Bonetti, Benedetta Tugnoli, Andrea Piva, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
Thymol as an Adjuvant to Restore Antibiotic Efficacy and Reduce Antimicrobial Resistance and Virulence Gene Expression in Enterotoxigenic <i>Escherichia coli</i> StrainsAndrea Bonetti, Benedetta Tugnoli, Andrea Piva, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2020
Financial toxicity and cancer treatments: Help from biosimilars - The explanatory case of bevacizumabJacopo Giuliani, Francesco Fiorica, Vito Albanese, et al.
Recenti Progressi in Medicina|December 20, 2021
The optimal duration of immune checkpoint inhibitors in non-oncogene addicted non-small cell lung cancer: less is more? An open questionJacopo Giuliani, Ugo Navarro, Beatrice Mantoan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 5, 2021
Cost-effectiveness of consolidation durvalumab after chemo-radiotherapy in stage III non-small-cell lung cancer: A cost-effective changeJacopo Giuliani, Maurizio Valentino Infante, Claudio Micheletto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 18, 2011
Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experiencePaolo Piacentini, Emilia Durante, Annarita Trolese, et al.
Recenti Progressi in Medicina|June 15, 2021
Computerization during the antineoplastic compounding process guarantees greater adherence to evidence-based medicine for the prophylaxis of chemotherapy-induced nausea and vomitingJacopo Giuliani, Beatrice Mantoan, Eva Pigozzi, et al.
Journal of Palliative Medicine|June 11, 2013
The effect of palliative care on the assistance of terminally ill cancer patientsJacopo Giuliani, Luisa Andreetta, Oliviero Zanardi, et al.
Frontiers in Veterinary Science|October 16, 2023
A blend of selected botanicals maintains intestinal epithelial integrity and reduces susceptibility to <i>Escherichia coli</i> F4 infection by modulating acute and chronic inflammation <i>in vitro</i>Andrea Bonetti, Andrea Toschi, Benedetta Tugnoli, et al.
Pageof 14